ELISA (Enzyme-linked immunosorbent assay)

4,638views

ELISA (Enzyme-linked immunosorbent assay)

Joana

Joana

Mycobacterium tuberculosis (Tuberculosis)
Tuberculosis: Pathology review
Diabetes insipidus
Diabetes mellitus
Hypoglycemics: Insulin secretagogues
Thyroid cancer
Thyroid nodules and thyroid cancer: Clinical
Diabetes mellitus: Clinical
Hypertriglyceridemia
Anatomy of the thyroid and parathyroid glands
Insulins
Diabetes mellitus
Adrenal masses: Pathology review
Adrenal masses and tumors: Clinical
Adrenal insufficiency: Pathology review
Primary adrenal insufficiency
Congenital adrenal hyperplasia
Adrenal gland histology
Adrenal masses: Pathology review
Adrenal masses and tumors: Clinical
Esophageal cancer
Gastric cancer
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Peptic ulcers and stomach cancer: Clinical
Colorectal cancer
Colorectal cancer: Clinical
Metaplasia and dysplasia
Diabetic nephropathy
Benign liver tumors
Hepatocellular carcinoma
Peptic ulcer
Peptic ulcer
Helicobacter pylori
Cirrhosis
Inflammatory bowel disease: Pathology review
Inflammatory bowel disease: Clinical
Gallbladder carcinoma
Wilson disease
Pancreatic cancer
Carcinoid syndrome
Acromegaly
Viral hepatitis
Hyperthyroidism: Clinical
Alcohol-associated liver disease
Non-alcoholic fatty liver disease
Pituitary adenoma
Non-steroidal anti-inflammatory drugs
Diarrhea: Clinical
Metabolic acidosis
Metabolic alkalosis
Ulcerative colitis
Crohn disease
Respiratory acidosis
Nephrotic syndromes: Pathology review
Goodpasture syndrome
Nephritic syndromes: Pathology review
Respiratory alkalosis
Cholestatic liver disease
Laxatives and cathartics
Polycystic ovary syndrome
MEN syndromes: Clinical
Autoimmune polyglandular syndrome type 1 (NORD)
Type I and type II errors
Gastroesophageal reflux disease (GERD)
Celiac disease
Polycystic kidney disease
Chronic kidney disease
Acute kidney injury: Clinical
IgA nephropathy (NORD)
Focal segmental glomerulosclerosis (NORD)
Minimal change disease
Chronic kidney disease: Clinical
Cytomegalovirus infection after transplant (NORD)
Hyperkalemia: Clinical
Atherosclerosis and arteriosclerosis: Pathology review
Portal hypertension
Cirrhosis: Clinical
Hypercholesterolemia: Clinical
Gallbladder histology
Chronic cholecystitis
Gout
Gout and pseudogout: Pathology review
Lesch-Nyhan syndrome
Macrocytic anemia: Pathology review
Alpha-thalassemia
Beta-thalassemia
Anemia: Clinical
Sickle cell disease (NORD)
Sickle cell disease: Clinical
Aplastic anemia
Von Willebrand disease
Acute leukemia
Lung cancer: Clinical
Lung cancer
Breast cancer: Clinical
Breast cancer
Monoclonal antibodies
Atrioventricular block
Heart blocks: Pathology review
Abnormal heart sounds
Heart failure
Pulmonary embolism
Pulmonary edema
Pulmonary valve disease
Cell-mediated immunity of CD4 cells
Cell-mediated immunity of natural killer and CD8 cells
Innate immune system
Introduction to the immune system
Complement system
T-cell development
B-cell development
MHC class I and MHC class II molecules
T-cell activation
B-cell activation, differentiation, and contraction
Antibody classes
Somatic hypermutation and affinity maturation
VDJ rearrangement
Contracting the immune response and peripheral tolerance
B- and T-cell memory
Vaccinations
Type I hypersensitivity
Food allergy
Anaphylaxis
Asthma
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
Graft-versus-host disease
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
ELISA (Enzyme-linked immunosorbent assay)
Gel electrophoresis and genetic testing
Fluorescence in situ hybridization
Precipitation reactions
Isolated primary immunoglobulin M deficiency
Selective immunoglobulin A deficiency
Blood groups and transfusions
Systemic lupus erythematosus
Systemic lupus erythematosus (SLE): Pathology review
Systemic lupus erythematosus (SLE): Clinical
Chronic granulomatous disease
Complement deficiency
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
DiGeorge syndrome
X-linked agammaglobulinemia
Hyper IgM syndrome
Leukocyte adhesion deficiency
Immunodeficiencies: Clinical
HIV (AIDS)
Cell-cell junctions
Hashimoto thyroiditis
Wiskott-Aldrich syndrome
Food allergies and EpiPens: Information for patients and families (The Primary School)
Vaccinations: Clinical
Blood products and transfusion: Clinical
Hypersensitivity skin reactions: Clinical
Shock: Clinical
Rheumatic heart disease
Immune thrombocytopenia
Rheumatoid arthritis
Rheumatoid arthritis: Clinical
Multiple sclerosis

Transcript

Watch video only

Enzyme-linked immunosorbent assay - or ELISA for short - is a laboratory technique or assay where antibodies or antigens in people’s samples are immobilized in a surface, and then detected by an antibody with an enzyme attached that causes a change of color.

So it’s useful to diagnose infections, such as HIV, hepatitis B, or malaria; and autoimmune diseases, like Graves’ disease, systemic lupus erythematosus, or rheumatoid arthritis, where the body reacts to its own proteins as if they were foreign antigens.

Immune response

We are constantly surrounded by harmful microorganisms called pathogens, that could cause a lot of damage if it wasn’t for the immune system.

These pathogens have unique parts called antigens.

Now, B lymphocytes are cells of the immune system that can detect those antigens and trigger an immune response by secreting lots and lots of antibodies.

These antibodies, also called immunoglobulins or Ig, are Y-shaped proteins that have two regions: the constant fragment region, also called Fc, that determines the antibody class - IgD, IgM, IgG, IgA, or IgE; and two fragment-antigen binding, or Fab regions, that recognize and bind to the antigen in order to inactivate it, preventing the pathogen from reaching its target cell and causing damage.

Principle of ELISA

Now, the basic idea with ELISA is to use that specific link between the antigen and antibody to help diagnose infections or autoimmune diseases.

More specifically, ELISA can be used to look for either the pathogen’s antigens or the antibodies our body secretes against them.

More than that, it also makes them visible or measurable by using an antibody against the suspected antigen or antibody.

But this antibody comes with a +1: it has an enzyme attached, which can modify a substrate called a chromogen.

Chromogen literally means that it generates color, so the change in color determines whether the test is positive or negative.

So, think of an ELISA test like a cooking recipe.

We’re going to need a cooking pot, and some ingredients, or reagents.

The cooking pot is a transparent plate with 96 wells, that’s made up of a special material that allows proteins to easily attach to its surface, including the walls and the bottom of the wells.

And there are seven reactants: the patient’s serum sample; some nonspecific proteins, like bovine serum albumin or casein, that don’t interact with any other reactant but can only attach to the well’s surface; the enzyme-linked antibody; the chromogenic substrate; a saline solution combined with non-ionic detergent used to wash the wells between every step of the procedure; a stop solution, like sulfuric acid; and two control samples, a positive control, that is a solution known to have the antigen or antibody you expect to find, and a negative control that doesn’t have the antigen or antibody.

Now, there are three main types of ELISA: direct, indirect, and sandwich ELISA. And depending on the type, other reactants may be needed.

So, with ELISA, a positive control is put in one of the wells, a negative control in another, and as many samples as needed in the rest of the wells.

You can put one sample in each well, so a lot of patients can be tested with a single ELISA plate.

But let’s rewind a little and zoom in on one of the 96 wells of the plate to see how this whole thing works.

Direct ELISA

So let’s take a look at direct ELISA to get started, which is used to detect antigens.

First, the serum sample is put in the well and incubated.

During this time, the proteins present in the sample, among them the expected antigen, adhere to the surface of the well.

After that, the exceeding sample solution is discarded and the well is washed a few times, so that only the attached proteins remain in the surface.

However, some empty gaps between them could remain.

If these are left empty, the enzyme-linked antibody that’s added next, could bind to these sticky sites and give a false positive reaction.

So next, nonspecific proteins are added, which attach to all the remaining gaps.

Key Takeaways

ELISA is a biochemical assay used in immunology to detect the presence of an antigen, antibody, or another protein. It takes its name from the enzyme-linked immunosorbent assay (ELISA).

The basic principle behind ELISA is that if an antigen or antibody is present in a sample, it will bind to a specific antibody or antigen attached to a solid support. The bound antigen or antibody can then be detected using an enzyme-linked secondary antibody that recognizes the primary antibody or antigen. The presence of this enzyme can be detected using various methods depending on the assay format, such as spectrophotometry, fluorimetry, or chemiluminescence. ELISA is a very sensitive assay that can detect minute levels of antigens or antibodies in a sample. It is often used to measure the concentration of proteins in body fluids, such as serum or urine.